Pharmaceutical companies are making a pitch to Prime Minister Narendra Modi to subsidise health insurance with a view to make it universal.
"We would like the government to provide health insurance on the lines of ObamaCare. Let the people pay for insurance. I am not saying the government pay for it. But today if one wants to avail health insurance it costs Rs Rs 4,000-5,000. Insurance companies will be able to offer cover at reduced premiums if they get aggregated demand or government gives a part subsidy. This way people in India can get quality health care," said Annaswamy Vaidheesh, GSK Pharmaceuticals' managing director in India.
Vaidheesh said GSK and other members of Organisation of Pharmaceutical Producers of India (OPPI) along with industry body Confederation of Indian Industry (CII) are discussing the proposal. "We are working on action plan and we will submit it to the government. If we are able to introduce this it will transform health delivery in India.," he added.
"Health insurance is most under-penetrated in India and the health sector is most neglected aspect of policy making. We hope this is rectified. We are in constant discussions with the government," added Ranjit Shahani, vice chairman of Novartis India.
In 2010 the US government enacted the Patient Protection and Affordable Care Act (known as ObamaCare) to give more Americans access to affordable, quality health insurance and to reduce the growth in health care spending.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)